Microbial biosynthesis of designer outer membrane vesicles

Current Opinion in Biotechnology

Volumn 29, Issue 1, 2014, Pages 76-84

  Baker, Jenny L ^a   Chen, Linxiao ^a   Rosenthal, Joseph A ^a   Putnam, David ^a   DeLisa, Matthew P ^a  

^a Cornell University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; BIOCHEMISTRY; PROTEINS; VACCINES;

CELLULOSIC SUBSTRATES; GENOME ENGINEERING; GRAM-NEGATIVE BACTERIA; LIPOPOLYSACCHARIDES; MICROBIAL BIOSYNTHESIS; OUTER MEMBRANE VESICLES; PROTEOLIPOSOMES; VESICLE BIOGENESIS;

BIOSYNTHESIS;

LIPOPOLYSACCHARIDE; OUTER MEMBRANE PROTEIN;

BACTERIAL GENE; BACTERIAL GENOME; BACTERIOLYSIS; BIOGENESIS; BIOSYNTHESIS; CYTOPLASM; DETOXIFICATION; DNA MODIFICATION; ESCHERICHIA COLI; GENE DELETION; GRAM NEGATIVE BACTERIUM; HELICOBACTER PYLORI; MEMBRANE VESICLE; NONHUMAN; OUTER MEMBRANE VESICLE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW; SHIGELLA SONNEI; ANIMAL; BACTERIA; BIOENGINEERING; CELL MEMBRANE; HUMAN; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BACTERIA; BIOENGINEERING; BIOLOGICAL TRANSPORT; CELL MEMBRANE; HUMANS;

EID: 84896448187     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2014.02.018     Document Type: Review

References (68)

1. Kulp A., Kuehn M.J. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol 2010, 64:163-184.
2. Schwechheimer C., Sullivan C.J., Kuehn M.J. Envelope control of outer membrane vesicle production in Gram-negative bacteria. Biochemistry 2013, 52:3031-3040.
3. McBroom A.J., Kuehn M.J. Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response. Mol Microbiol 2007, 63:545-558.
4. Macdonald I.A., Kuehn M.J. Stress-induced outer membrane vesicle production by Pseudomonas aeruginosa. J Bacteriol 2013, 195:2971-2981.
5. Kobayashi H., Uematsu K., Hirayama H., Horikoshi K. Novel toluene elimination system in a toluene-tolerant microorganism. J Bacteriol 2000, 182:6451-6455.
6. Manning A.J., Kuehn M.J. Contribution of bacterial outer membrane vesicles to innate bacterial defense. BMC Microbiol 2011, 11:258.
7. Loeb M.R. Bacteriophage T4-mediated release of envelope components from Escherichia coli. J Virol 1974, 13:631-641.
8. Loeb M.R., Kilner J. Release of a special fraction of the outer membrane from both growing and phage T4-infected Escherichia coli B. Biochim Biophys Acta 1978, 514:117-127.
9. Schooling S.R., Beveridge T.J. Membrane vesicles: an overlooked component of the matrices of biofilms. J Bacteriol 2006, 188:5945-5957.
10. Furuta N., Takeuchi H., Amano A. Entry of Porphyromonas gingivalis outer membrane vesicles into epithelial cells causes cellular functional impairment. Infect Immun 2009, 77:4761-4770.
11. Kesty N.C., Mason K.M., Reedy M., Miller S.E., Kuehn M.J. Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J 2004, 23:4538-4549.
12. Gankema H., Wensink J., Guinee P.A., Jansen W.H., Witholt B. Some characteristics of the outer membrane material released by growing enterotoxigenic Escherichia coli. Infect Immun 1980, 29:704-713.
13. Kato S., Kowashi Y., Demuth D.R. Outer membrane-like vesicles secreted by Actinobacillus actinomycetemcomitans are enriched in leukotoxin. Microb Pathog 2002, 32:1-13.
14. Bomberger J.M., Maceachran D.P., Coutermarsh B.A., Ye S., O'Toole G.A., Stanton B.A. Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog 2009, 5:e1000382.
15. Kolling G.L., Matthews K.R. Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7. Appl Environ Microbiol 1999, 65:1843-1848.
16. Kuehn M.J., Kesty N.C. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev 2005, 19:2645-2655.
17. Ellis T.N., Kuehn M.J. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev 2010, 74:81-94.
18. Mashburn-Warren L.M., Whiteley M. Special delivery: vesicle trafficking in prokaryotes. Mol Microbiol 2006, 61:839-846.
19. Rosenthal J.A., Chen L., Baker J.L., Putnam D., DeLisa M.P. Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale. Curr Opin Biotechnol 2013, 28:51-58.
20. Collins B.S. Gram-negative outer membrane vesicles in vaccine development. Discov Med 2011, 12:7-15.
21. Camacho A.I., de Souza J., Sanchez-Gomez S., Pardo-Ros M., Irache J.M., Gamazo C. Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice. Vaccine 2011, 29:8222-8229.
22. Pierson T., Matrakas D., Taylor Y.U., Manyam G., Morozov V.N., Zhou W., van Hoek M.L. Proteomic characterization and functional analysis of outer membrane vesicles of Francisella novicida suggests possible role in virulence and use as a vaccine. J Proteome Res 2011, 10:954-967.
23. Schild S., Nelson E.J., Bishop A.L., Camilli A. Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera. Infect Immun 2009, 77:472-484.
24. Gorringe A.R., Pajon R. Bexsero: a multicomponent vaccine for prevention of meningococcal disease. Hum Vaccin Immunother 2012, 8:174-183.
25. Chatterjee S., Chaudhuri K. Outer Membrane Vesicles of Bacteria 2012, Springer, Berlin, Heidelberg.
26. Manabe T., Kato M., Ueno T., Kawasaki K. Flagella proteins contribute to the production of outer membrane vesicles from Escherichia coli W3110. Biochem Biophys Res Commun 2013, 441:151-156.
27. Shetty A., Chen S., Tocheva E.I., Jensen G.J., Hickey W.J. Nanopods: a new bacterial structure and mechanism for deployment of outer membrane vesicles. PLoS ONE 2011, 6:e20725.
28. Gerding M.A., Ogata Y., Pecora N.D., Niki H., de Boer P.A. The trans-envelope Tol-Pal complex is part of the cell division machinery and required for proper outer-membrane invagination during cell constriction in E. coli. Mol Microbiol 2007, 63:1008-1025.
29. Bernadac A., Gavioli M., Lazzaroni J.C., Raina S., Lloubes R. Escherichia coli tol-pal mutants form outer membrane vesicles. J Bacteriol 1998, 180:4872-4878.
30. McBroom A.J., Johnson A.P., Vemulapalli S., Kuehn M.J. Outer membrane vesicle production by Escherichia coli is independent of membrane instability. J. Bacteriol 2006, 188:5385-5392.
31. Henry T., Pommier S., Journet L., Bernadac A., Gorvel J.P., Lloubes R. Improved methods for producing outer membrane vesicles in Gram-negative bacteria. Res Microbiol 2004, 155:437-446.
32. Berlanda Scorza F., Colucci A.M., Maggiore L., Sanzone S., Rossi O., Ferlenghi I., Pesce I., Caboni M., Norais N., Di Cioccio V., et al. High yield production process for Shigella outer membrane particles. PLoS ONE 2012, 7:e35616.
33. Chen D.J., Osterrieder N., Metzger S.M., Buckles E., Doody A.M., DeLisa M.P., Putnam D. Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proc Natl Acad Sci USA 2010, 107:3099-3104.
34. Kim J.Y., Doody A.M., Chen D.J., Cremona G.H., Shuler M.L., Putnam D., DeLisa M.P. Engineered bacterial outer membrane vesicles with enhanced functionality. J Mol Biol 2008, 380:51-66.
35. Berlanda Scorza F., Doro F., Rodriguez-Ortega M.J., Stella M., Liberatori S., Taddei A.R., Serino L., Gomes Moriel D., Nesta B., Fontana M.R., et al. Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli DeltatolR IHE3034 mutant. Mol Cell Proteomics 2008, 7:473-485.
36. Tseng Y.T., Wang S.W., Kim K.S., Wang Y.H., Yao Y., Chen C.C., Chiang C.W., Hsieh P.C., Teng C.H. NlpI facilitates deposition of C4 bp on Escherichia coli by blocking classical complement-mediated killing, which results in high-level bacteremia. Infect Immun 2012, 80:3669-3678.
37. Wai S.N., Lindmark B., Soderblom T., Takade A., Westermark M., Oscarsson J., Jass J., Richter-Dahlfors A., Mizunoe Y., Uhlin B.E. Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell 2003, 115:25-35.
38. Horstman A.L., Kuehn M.J. Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin via outer membrane vesicles. J Biol Chem 2000, 275:12489-12496.
39. Haurat M.F., Aduse-Opoku J., Rangarajan M., Dorobantu L., Gray M.R., Curtis M.A., Feldman M.F. Selective sorting of cargo proteins into bacterial membrane vesicles. J Biol Chem 2011, 286:1269-1276.
40. Evans A.G., Davey H.M., Cookson A., Currinn H., Cooke-Fox G., Stanczyk P.J., Whitworth D.E. Predatory activity of Myxococcus xanthus outer-membrane vesicles and properties of their hydrolase cargo. Microbiology 2012, 158:2742-2752.
41. Beveridge T.J. Structures of gram-negative cell walls and their derived membrane vesicles. J Bacteriol 1999, 181:4725-4733.
42. Lee E.Y., Bang J.Y., Park G.W., Choi D.S., Kang J.S., Kim H.J., Park K.S., Lee J.O., Kim Y.K., Kwon K.H., et al. Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli. Proteomics 2007, 7:3143-3153.
43. Kesty N.C., Kuehn M.J. Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles. J Biol Chem 2004, 279:2069-2076.
44. Muralinath M., Kuehn M.J., Roland K.L., Curtiss R. Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae. Infect Immun 2011, 79:887-894.
45. Bartolini E., Ianni E., Frigimelica E., Petracca R., Galli G., Berlanda Scorza F., Norais N., Laera D., Giusti F., Pierleoni A., et al. Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro. J Extracell Vesicles 2013, 2:20181.
46. O'Dwyer C.A., Reddin K., Martin D., Taylor S.C., Gorringe A.R., Hudson M.J., Brodeur B.R., Langford P.R., Kroll J.S. Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential. Infect Immun 2004, 72:6511-6518.
47. Jose J., Meyer T.F. The autodisplay story, from discovery to biotechnical and biomedical applications. Microbiol Mol Biol Rev 2007, 71:600-619.
48. Schroeder J., Aebischer T. Recombinant outer membrane vesicles to augment antigen-specific live vaccine responses. Vaccine 2009, 27:6748-6754.
49. van Bloois E., Winter R.T., Kolmar H., Fraaije M.W. Decorating microbes: surface display of proteins on Escherichia coli. Trends Biotechnol 2011, 29:79-86.
50. van der Ley P., van der Biezen J., Poolman J.T. Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine. Vaccine 1995, 13:401-407.
51. Tsai S.L., Oh J., Singh S., Chen R., Chen W. Functional assembly of minicellulosomes on the Saccharomyces cerevisiae cell surface for cellulose hydrolysis and ethanol production. Appl Environ Microbiol 2009, 75:6087-6093.
52. Raetz C.R., Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 2002, 71:635-700.
53. van de Waterbeemd B., Streefland M., van der Ley P., Zomer B., van Dijken H., Martens D., Wijffels R., van der Pol L. Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process. Vaccine 2010, 28:4810-4816.
54. Ferrari G., Garaguso I., Adu-Bobie J., Doro F., Taddei A.R., Biolchi A., Brunelli B., Giuliani M.M., Pizza M., Norais N., et al. Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles. Proteomics 2006, 6:1856-1866.
55. van der Ley P., van den Dobbelsteen G. Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants. Hum Vaccin 2011, 7:886-890.
56. van der Ley P., Steeghs L., Hamstra H.J., ten Hove J., Zomer B., van Alphen L. Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. Infect Immun 2001, 69:5981-5990.
57. Lee D.H., Kim S.H., Kang W., Choi Y.S., Lee S.H., Lee S.R., You S., Lee H.K., Chang K.T., Shin E.C. Adjuvant effect of bacterial outer membrane vesicles with penta-acylated lipopolysaccharide on antigen-specific T cell priming. Vaccine 2011, 29:8293-8301.
58. Kim S.H., Kim K.S., Lee S.R., Kim E., Kim M.S., Lee E.Y., Gho Y.S., Kim J.W., Bishop R.E., Chang K.T. Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles. Biochim Biophys Acta 2009, 1788:2150-2159.
59. Lee S.R., Kim S.H., Jeong K.J., Kim K.S., Kim Y.H., Kim S.J., Kim E., Kim J.W., Chang K.T. Multi-immunogenic outer membrane vesicles derived from an MsbB-deficient Salmonella enterica serovar typhimurium mutant. J Microbiol Biotechnol 2009, 19:1271-1279.
60. Asensio C.J., Gaillard M.E., Moreno G., Bottero D., Zurita E., Rumbo M., van der Ley P., van der Ark A., Hozbor D. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate. Vaccine 2011, 29:1649-1656.
61. Cullen T.W., Giles D.K., Wolf L.N., Ecobichon C., Boneca I.G., Trent M.S. Helicobacter pylori versus the host: remodeling of the bacterial outer membrane is required for survival in the gastric mucosa. PLoS Pathog 2011, 7:e1002454.
62. Tran A.X., Karbarz M.J., Wang X., Raetz C.R., McGrath S.C., Cotter R.J., Trent M.S. Periplasmic cleavage and modification of the 1-phosphate group of Helicobacter pylori lipid A. J Biol Chem 2004, 279:55780-55791.
63. Dubensky T.W., Reed S.G. Adjuvants for cancer vaccines. Semin Immunol 2010, 22:155-161.
64. Needham B.D., Carroll S.M., Giles D.K., Georgiou G., Whiteley M., Trent M.S. Modulating the innate immune response by combinatorial engineering of endotoxin. Proc Natl Acad Sci USA 2013, 110:1464-1469.
65. Han Y., Li Y., Chen J., Tan Y., Guan F., Wang X. Construction of monophosphoryl lipid A producing Escherichia coli mutants and comparison of immuno-stimulatory activities of their lipopolysaccharides. Mar Drugs 2013, 11:363-376.
66. Sanders H., Feavers I.M. Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines. Expert Rev Vaccines 2011, 10:323-334.
67. Arenas J., van Dijken H., Kuipers B., Hamstra H.J., Tommassen J., van der Ley P. Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity. Clin Vaccine Immunol 2010, 17:487-495.
68. Reynolds C.M., Ribeiro A.A., McGrath S.C., Cotter R.J., Raetz C.R., Trent M.S. An outer membrane enzyme encoded by Salmonella typhimurium lpxR that removes the 3'-acyloxyacyl moiety of lipid A. J Biol Chem 2006, 281:21974-21987.